Jacob Ballon, MD
Psychiatry · Palo Alto, CANPI 1083835474
Payments from drug & device makers
Across 603 payments — averaging $2902.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$565K
- E.r. Squibb & Sons, L.L.C.$384K
- Boehringer Ingelheim$233K
- Hoffmann-la Roche Limited$192K
- Janssen Research & Development, LLC$123K
- Boehringer Ingelheim International GmbH$105K
- plus $148K from 13 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 284 | $565,230 |
| E.r. Squibb & Sons, L.L.C. | 11 | $384,170 |
| Boehringer Ingelheim | 32 | $232,517 |
| Hoffmann-la Roche Limited | 29 | $191,928 |
| Janssen Research & Development, LLC | 16 | $123,054 |
| Boehringer Ingelheim International GmbH | 79 | $105,013 |
| Corcept Therapeutics | 15 | $76,756 |
| Teva Pharmaceuticals USA, Inc. | 85 | $46,371 |
| H. Lundbeck A S | 7 | $7,347 |
| Boehringer Ingelheim RCV GmbH & Co KG | 2 | $5,154 |
| Neurocrine Biosciences, Inc. | 21 | $5,122 |
| Genentech, Inc. | 1 | $3,049 |
| Indivior Inc. | 6 | $2,474 |
| AbbVie(2 entities) | 4 | $701 |
| Pfizer | 1 | $700 |
| Sunovion Pharmaceuticals Inc. | 5 | $324 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $124 |
| Acadia Pharmaceuticals Inc | 1 | $64 |
| Avanir Pharmaceuticals, Inc. | 1 | $30 |
How this compares
$1,750,125 in reported general payments places this provider in the 95th percentile of 4,954 psychiatry providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatry in Palo Alto
- Elly LeeIrvine$49.8M
- Daniel ChuehOrange$17.9M
- Eric ChavezSan Diego$15.5M
- Lara ShirikjianTorrance$12.6M
- John DuffySanta Ana$12M
- Marina BusselPlaya Vista$12M
- Sherry SoefjeOceanside$11.9M
- Steven MacinaHuntington Beach$11.1M
- Wakelin McNeelRosemead$11M
- Donald AndersonBanning$10.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.